by Alessandro Ricci, 3DIFIC
Although there are 3D printing case reports in almost every subspecialty of medicine to date, the rate of adoption in the field of congenital heart disease is particularly advanced. This is due, in no small part, to the fact that the heart is a hollow organ, which makes it a perfect substrate for 3D printing. More importantly, medical decision-making in CHD is informed by assessment of the anatomic morphology of the heart because cardiac pathology is a direct manifestation of the underlying 3D structure.
Reports on the application of 3D printing in the study and treatment of CHD are accumulating rapidly; these studies cover uses, including advanced visualization, surgical planning, and education. Individual case reports and small studies indicate the potential to improve patient outcomes using patient-specific 3D models. There is a growing body of literature that demonstrates the value of 3D models in decision-making, procedural planning, and postoperative care simulation.
First our case is Tetralogy of Fallot with absent pulmonary valve. Absent pulmonary valve syndrome is a rare cardiac malformation, and characterised by a dysplastic or rudimentary pulmonary valve associated with varying degrees of hypoplasia of the pulmonary annulus. Owing to the concomitant occurrence of valve stenosis and regurgitation, absent pulmonary valve syndrome is almost always associated with massive enlargement of the pulmonary trunk and its branches. The perinatal mortality rate of tetralogy of Fallot with absent pulmonary valve syndrome is above 60%, closely related to the existence of severe heart failure, respiratory distress, and/or associated malformations.
(3DIFIC has started a partnership with the Almazov National Medical Research Center -St. Petersburg, Russia-, one of the most important centers for pediatric cardiosurgery. The activities are carried on by the team of Cardio Pediatric Surgery: Igor Averkin, Evgeny Grehov, Alexandr Latipov, Elena Vasechkina, Tat’iana Pervunina)
What drives you?
Ours is a private company, therefore we are continuously looking for partnerships that allow us to reach new levels in 3D printing applied to medicine.
Why should the delegate attend your presentation?
Our presentation shows that a collaboration between specific, deep capabilities in mastering digitization and 3D printing, a strong, specific knowledge in anathomy and surgery, together with the desire to solve complex problems, leads to outstanding solutions in finding a more performing medical practice.
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
No idea: the time of history is too complex.
What kind of impact do you expect them to have?
Massive, we’re in a fluid condition, nowadays.
This will be our 3rd participation at 3D Medical Printing Conference. It’s always been an elective place where to share experiences, find partners, start projects, and learn about how 3D printing and digitization are rapidly impacting on medicine. We recommend everyone that has a stake in healthcare, starting with decision makers, to attend in order to get at least the basic information of this silent revolution that is going on. This changing will impact rapidly all the industry and players have to stay informed about that.
About Alessandro Ricci
Alessandro Ricci, the Managing Director of 3DIFIC, describes himself as Confusion Maker, who has had a herratic career from data entry, to international commercial office manager, to business consultant to entrepreneur, to pseudo scientist (today).
About 3DIFIC s.r.l.
One of the many 3D printing company that was born in 2015, with many good ideas and a passion for this technology. We started to work in medicine very early and had the luck to interact with exceptional and proactive medical professionals. We develop all sorts of project, especially in the medical field.
Our mission is TO DELIVER TO DOCTORS ANY PATIENT SPECIFIC DEVICES THEY WANT